E-viri
PDF
Recenzirano
Odprti dostop
-
An, Zhenyi; Aksoy, Ozlem; Zheng, Tina; Fan, Qi-Wen; Weiss, William A
Oncogene, 03/2018, Letnik: 37, Številka: 12Journal Article
Amplification of epidermal growth factor receptor (EGFR) and its active mutant EGFRvIII occurs frequently in glioblastoma (GBM). While EGFR and EGFRvIII play critical roles in pathogenesis, targeted therapy with EGFR-tyrosine kinase inhibitors (TKIs) or antibodies has only shown limited efficacy in patients. Here we discuss signaling pathways mediated by EGFR/EGFRvIII, current therapeutics, and novel strategies to target EGFR/EGFRvIII-amplified GBM.
